We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$39.9B
AUM Growth
-$3.99B
Cap. Flow
-$1.18B
Cap. Flow %
-2.97%
Top 10 Hldgs %
37.22%
Holding
1,874
New
146
Increased
562
Reduced
366
Closed
20

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$543M
2
NVDA icon
NVIDIA
NVDA
+$373M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$178M
4
ABBV icon
AbbVie
ABBV
+$149M
5
MSFT icon
Microsoft
MSFT
+$146M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$598M
2
NFLX icon
Netflix
NFLX
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$239M
4
AMZN icon
Amazon
AMZN
+$217M
5
V icon
Visa
V
+$175M

Sector Composition

Rank Sector Weight
1 Technology 37.27%
2 Financials 12.41%
3 Healthcare 11.52%
4 Communication Services 10.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFST icon
1801
Lifestance Health
LFST
$4.17B
$29K ﹤0.01%
+4,523
New +$31.5K
PAHC icon
1802
Phibro Animal Health
PAHC
$1.38B
$29K ﹤0.01%
+519
New +$24.7K
PHR icon
1803
Phreesia
PHR
$603M
$29K ﹤0.01%
3,449
– –
RDW icon
1804
Redwire
RDW
$2.16B
$29K ﹤0.01%
+3,369
New +$33K
TRVI icon
1805
Trevi Therapeutics
TRVI
$2.46B
$29K ﹤0.01%
+2,464
New +$27.6K
ANIP icon
1806
ANI Pharmaceuticals
ANIP
$1.79B
$28K ﹤0.01%
+368
New +$28.7K
ESTA icon
1807
Establishment Labs
ESTA
$2.74B
$28K ﹤0.01%
+487
New +$33.3K
IE icon
1808
Ivanhoe Electric
IE
$1.41B
$28K ﹤0.01%
+2,408
New +$37.7K
NSP icon
1809
Insperity
NSP
$1.88B
$28K ﹤0.01%
1,045
– –
VYX icon
1810
NCR Voyix
VYX
$1.02B
$28K ﹤0.01%
4,362
– –
PVLA
1811
Palvella Therapeutics
PVLA
$2.03B
$28K ﹤0.01%
+224
New +$23.4K
MUX icon
1812
McEwen Inc
MUX
$1.03B
$27K ﹤0.01%
+1,343
New +$31.9K
RYZ
1813
Ryerson Holding Corp
RYZ
$1.57B
$27K ﹤0.01%
+1,197
New +$31.2K
SKYT icon
1814
SkyWater Technology
SKYT
$1.49B
$27K ﹤0.01%
+976
New +$28.7K
TTI icon
1815
TETRA Technologies
TTI
$1.3B
$27K ﹤0.01%
+3,132
New +$31.4K
XERS icon
1816
Xeris Biopharma Holdings
XERS
$1.44B
$27K ﹤0.01%
+4,573
New +$30.3K
AMLX icon
1817
Amylyx Pharmaceuticals
AMLX
$1.96B
$26K ﹤0.01%
+1,863
New +$26.2K
JBI icon
1818
Janus International
JBI
$722M
$26K ﹤0.01%
4,995
– –
NSSC icon
1819
Napco Security Technologies
NSSC
$1.26B
$26K ﹤0.01%
+651
New +$27.3K
REAL icon
1820
The RealReal
REAL
$1.31B
$26K ﹤0.01%
+2,814
New +$35.6K
BFLY icon
1821
Butterfly Network
BFLY
$1.67B
$25K ﹤0.01%
+6,267
New +$24.2K
TLRY icon
1822
Tilray
TLRY
$490M
$25K ﹤0.01%
3,810
– –
RHLD
1823
Resolute Holdings Management
RHLD
$1.05B
$25K ﹤0.01%
+151
New +$27.5K
ASAN icon
1824
Asana
ASAN
$1.51B
$24K ﹤0.01%
3,699
– –
LMB icon
1825
Limbach Holdings
LMB
$876M
$24K ﹤0.01%
+305
New +$25.7K
71 72
73
74 75

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

KBC Group's Q1 2026 Portfolio in Review

As of Q1 2026, KBC Group held 1,874 positions worth $39.9B, down 9.1% from $43.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

KBC Group's Q1 2026 filing shows 146 new, 562 increased, 366 reduced and 20 closed positions. Its largest new stake was AbbVie: 669,647 shares worth $146M. The largest sale was Alphabet (Google) Class C, an estimated $598M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q1 2026 buy was AbbVie: 669,647 shares worth $146M.
  • KBC Group added most to Apple in Q1 2026, an estimated $543M increase.
  • KBC Group's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $598M.
  • KBC Group fully exited CyberArk in Q1 2026, selling an estimated $6.81M.
  • KBC Group's ten largest holdings make up 37% of its $39.9B portfolio in Q1 2026.
  • KBC Group opened 146 new positions and closed 20 in Q1 2026.
  • KBC Group's portfolio value fell 9.1% quarter-over-quarter to $39.9B.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.